The growing occurrence of genetic disorders like sickle cell anemia, cystic fibrosis, and muscular dystrophy is fueling the demand for gene therapy and genome editing solutions, as these approaches ...

How CRISPR therapy could cure everything from cancer ... where they help defend against viruses. The Cas9 protein is the most widely used by scientists. This protein can easily be programmed ...

Learn how CASGEVY, the first NHS-approved CRISPR gene therapy, treats sickle cell disease through a revolutionary genetic ...

Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...

Recent research from Duke University has demonstrated a promising new approach that could be used to treat a rare and complex ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

India is known as the “Thalassemia capital of the world.” It has the highest number of patients with thalassemia major in the world. India has around 50 million (5 crore) carriers of the ß ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...

Recent headlines in the U.K. lauded the approval of a new sickle cell cure using gene-editing technology. Columnist Mary ...